Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents

Clinical trial NCT00534638 · COMPLETED

Trial details

NCT number: NCT00534638
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Infections, Papillomavirus

Start date: 2007-10-04
Primary completion: 2014-12-17
Enrollment: 34412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.